advertisement
11.13.2 Betablocker and carbon anhydrase inhibitor (5)
Showing records 1 to 5
Display all abstracts in classification 11.13.2 Betablocker and carbon anhydrase inhibitor
Search within classification 11.13.2 Betablocker and carbon anhydrase inhibitor28110 Efficacy and tolerability of preservative-free eye drops containing a fixed combination of dorzolamide and timolol in glaucoma patients
Renieri G; Fuhrer K; Scheithe K; Lorenz K; Pfeiffer N; Thieme H
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 597-603
28148 Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension
Bell NP; Ramos JL; Feldman RM
Clinical Ophthalmology 2010; 4: 1331-1346
28112 Bimatoprost and bimatoprost/timolol fixed combination in patients with open-angle glaucoma and ocular hypertension
Katsanos A; Dastiridou AI; Fanariotis M; Kotoula M; Tsironi EE
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 67-71
28144 Fixed combination of bimatoprost and timolol in patients with primary open-angle glaucoma or ocular hypertension with inadequate IOP adjustment
Brief G; Lammich T; Nagel E; Pfennigsdorf S; Spraul CW; Ho S
Clinical Ophthalmology 2010; 4: 1125-1129
28176 Travoprost/timolol fixed combination in the management of open-angle glaucoma: A clinical review
Denis P
Expert Opinion in Pharmacotherapy 2011; 12: 463-471
